NSC |
Compound |
Enrichment |
Correlation |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0164116791870034 |
0.26118632 |
NSC 22709 |
v-Triazolo[4,5-d]pyrimidin-7-ol |
0.0164116791870034 |
0.16514813 |
NSC 263434 |
N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine |
0.0164116791870034 |
-0.15373913 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0164116791870034 |
-0.0084368909 |
NSC 335995 |
Null |
0.0164116791870034 |
-0.006886926 |
NSC 349622 |
Cytovaricin |
0.0164116791870034 |
-0.12983475 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0164116791870034 |
0.36214303 |
NSC 359239 |
Antibiotic X-14766A |
0.0164116791870034 |
-0.18797656 |
NSC 363813 |
Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- |
0.0164116791870034 |
-0.039105484 |
NSC 617394 |
Null |
0.0164116791870034 |
0.17987348 |